Harvard Apparatus Regenerative Technology Inc. (HRGN)
OTCMKTS
· Delayed Price · Currency is USD
1.650
+0.050 (3.12%)
Dec 4, 2025, 4:00 PM EST
Harvard Apparatus Regenerative Technology Employees
Harvard Apparatus Regenerative Technology had 8 employees as of December 31, 2024. The number of employees decreased by 10 or -55.56% compared to the previous year.
Employees
8
Change (1Y)
-10
Growth (1Y)
-55.56%
Revenue / Employee
$92,875
Profits / Employee
-$815,750
Market Cap
31.76M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| Zomedica | 152 |
Harvard Apparatus Regenerative Technology News
- 1 year ago - Harvard Apparatus Regenerative Technology Announces Strategic Collaboration with Children's Hospital Capital institute of Pediatrics in Beijing, China to Advance Treatment for Esophageal Atresia - GlobeNewsWire
- 1 year ago - Harvard Apparatus Regenerative Technology Appoints Mao Zhang to Board of Directors - GlobeNewsWire
- 1 year ago - Harvard Apparatus Regenerative Technology Announces $5 Million Financing to Continue Clinical Trial - GlobeNewsWire
- 1 year ago - Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 1 year ago - Harvard Apparatus Regenerative Technology Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 years ago - Harvard Apparatus Regenerative Technology and the McGowan Institute for Regenerative Medicine at the University of Pittsburgh Establish a Research Collaboration to Study the Repair and Regeneration of the Colon following Colectomy - GlobeNewsWire
- 2 years ago - Harvard Apparatus Regenerative Technology and Renowned Professor/Physician Establish a Collaboration to Repair and Regenerate the Uterus - GlobeNewsWire
- 2 years ago - Harvard Apparatus Regenerative Technology Reports Third Quarter 2023 Financial Results - GlobeNewsWire